|
C18ORF10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.202600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.919600E-01 |
| Normal-vs-Stage2 |
6.512800E-01 |
| Normal-vs-Stage3 |
4.076400E-01 |
| Normal-vs-Stage4 |
2.300600E-01 |
| Stage1-vs-Stage2 |
7.907600E-01 |
| Stage1-vs-Stage3 |
8.618800E-01 |
| Stage1-vs-Stage4 |
5.468600E-01 |
| Stage2-vs-Stage3 |
7.407200E-01 |
| Stage2-vs-Stage4 |
4.941200E-01 |
| Stage3-vs-Stage4 |
6.923400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.438000E-01 |
| Normal-vs-AfricanAmerican |
4.124000E-01 |
| Normal-vs-Asian |
1.260430E-01 |
| Caucasian-vs-AfricanAmerican |
3.856100E-03 |
| Caucasian-vs-Asian |
5.501000E-01 |
| AfricanAmerican-vs-Asian |
1.697770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.022500E-02 |
| Normal-vs-Female |
2.412800E-01 |
| Male-vs-Female |
2.644200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.783000E-01 |
| Normal-vs-Extreme_Weight |
1.196310E-02 |
| Normal-vs-Obese |
4.210600E-01 |
| Normal-vs-Extreme_Obese |
5.987600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.162100E-02 |
| Normal_Weight-vs-Obese |
5.741000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.400200E-01 |
| Extreme_Weight-vs-Obese |
9.378100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.975200E-01 |
| Obese-vs-Extreme_Obese |
8.640800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.009200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.383200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.386770E-01 |
| Normal-vs-Age(81-100Yrs) |
1.169230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.143200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.364200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.454200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.502000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.883560E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.888200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.353800E-01 |
| Normal-VS-Type2 PRCC |
1.946230E-01 |
| Normal-VS-KIRP CIMP |
8.703900E-02 |
| Normal-VS-Unclassified PRCC |
4.605400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.300200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.906090E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.343000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.382400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.792600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.434300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.708820E-01 |
| Normal-vs-N1 |
2.903200E-01 |
| Normal-vs-N2 |
9.549200E-01 |
| N0-vs-N1 |
8.751600E-01 |
| N0-vs-N2 |
6.515200E-01 |
| N1-vs-N2 |
6.736600E-01 |
|
|
